Patient-centric clinical data science

Phesi’s award winning, AI-powered solutions deliver precision insights and accelerate clinical development.


  • Profiling patient populations using real-world data from 325m patients

  • Optimizing protocol design

  • Selecting lead enrolling countries and investigator sites

  • Enabling digital twins


Request a demo
What we do

Powered by the world’s largest clinical trials database, Phesi’s AI-driven solutions enable life sciences companies to accelerate drug development and commercialization. Turn real world clinical trial data into insights and answers with our Trial Accelerator™ platform generating Digital Patient Profiles, Digital Twins and Digital Trial Arms. Smarter trials, faster cures. Delivered.

Trial Accelerator
platform

Accelerate the design and execution of patient-centric trials with the world’s largest clinical trials database containing real-world data
Read more

Protocol Design Optimization

Eliminate costly trial failures and protocol amendments using modal design value simulation Read more

Digital Twin &
External Control Arm

Model diseases and patient outcomes using digital patient profiles and real-world data
Read more
What makes Phesi different

Data-driven clinical development

Real-world patient-centric data analytic solutions, trusted by the world’s leading pharmaceutical companies.

Optimizing program and protocol design by creating Digital Patient Profiles, Digital Twins and Digital Trial Arms, we can help you improve patient population accuracy and diversity, reduce trial timelines and patient burden, across every stage of clinical development for any indication, including rare diseases. 

The power behind every successful trial.

Read more

World’s largest clinical trials database containing real-world data

Trial Accelerator Platform enables predictive modelling in 4 key views: Patient Profile, Trial Performance, Country, Investigator Site

Digital Twin and Digital Trial Arm services generate reliable evidence without the expense or time needed in traditional trials

Powered by the Phesi proprietary integrated methodology and ground-breaking AI technologies

485 k

Curated clinical trials

4.2 m

Physicians

100 k

Updated data sources

325 m+

Patients

4000 +

Disease indications

our clients

Customer experience

Phesi is on the frontiers of defining clinical development as a science, performing systematic analysis of the clinical trial, clinical protocol, and clinical site space to form hypotheses about what will work and what will not. Through observation and experiment you are applying those learnings to inform new clinical programs or save old ones. Phesi is more than the sum of its parts and the value is in the integration.

FORMER SVP, GLOBAL CHIEF MEDICAL OFFICER AND US R&D HEAD Sanofi

Every global R&D leader should know about this and should be testing it within their portfolio.

senior director, clinical operations Takeda

Phesi worked with us to show that a particular adaptive trial design would give the best performance. The result was a significantly quicker and cheaper devel­opment time on this priority asset.

senior director, clinical operations Takeda
News & events
09. 08. 2026
New Trial Accelerator™ feature uses agents to extract and verify protocol data in minutes Read more
05. 13. 2026
Phesi analysis of more than 600,000 clinical trial protocols finds less than a third are linked to patient data Read more
04. 01. 2026
New Phesi data shows 6.7% of global clinical trials impacted by Middle East disruption Read more
02. 18. 2026
Phesi takes leading position on Frost and Sullivan’s Frost Radar™ for AI-enabled clinical trials Read more
01. 07. 2026
Breast cancer tops list of most-studied diseases for fifth consecutive year Read more
11. 06. 2025
Phesi wins the 2025 Clinical Trials Arena Excellence Award for Innovation Read more